** Shares of drug maker focused on blood related diseases
CTI BioPharma CTIC.O surge 83.3% to $8.84 premarket - biggest
pct. gainer across U.S. stock exchanges
** Drug maker Swedish Orphan Biovitrum SOBIV.ST (SOBI) has
agreed to make a $1.7 billion cash offer to buy CTIC
** Sobi said it would make a tender offer for $9.10 per CTIC
share, a premium of 89% over stock's closing price of $4.82 on
Tuesday
** Transaction is expected to close in the third quarter of
this year
** Up to Tuesday's close, stock had fallen ~20% YTD
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))